Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.
U.S. Treasurys may be losing their safe-haven status — and these bonds could take their place
After Israel attacked Iran on June 13, U.S. Treasury yields rose while other countries’ bond yields declined.
